Thyroid Cancer | Oncology Today with Dr Neil Love: Thyroid Cancer
Featuring an interview with Dr Eric Sherman, including the following topics: Changes in the incidence, mortality, and management of thyroid cancer in the past 20 years (0:00) Clinical presentation and histologic characteristics of thyroid cancer; genomic alterations associated with each histology (5:55) Initial management of thyroid cancer; current role of surgery and radioactive iodine in treatment algorithms (14:56) Current and future role of tumor biomarkers in treatment selection; emerging role of liquid biopsies in anaplastic thyroid cancer (20:23) Incidence and optimal treatment of brain metastases in patients with thyroid cancer; biologic rationale for tyrosine kinase inhibitors (TKIs) targeting VEGF and BRAF in thyroid cancer (24:20) Safety and tolerability of sorafenib and lenvatinib; management of BRAF-mutated disease (34:49) Management of tumors in patients with RET alterations or NTRK fusions; therapies for medullary tumors (39:28) Case: A woman in her early 60s with metastatic papillary thyroid cancer; ongoing research combining TKIs and immunotherapy for anaplastic thyroid cancer (50:35) Case: A man in his early 40s presenting with severe diarrhea and metastatic medullary thyroid cancer (1:00:54) CME information and select publications